A New Algorithm for Sampling Parameters in a Structured Correlation Matrix With Application to Estimating Optimal Combinations of Muscles to Quantify Progression in Duchenne Muscular Dystrophy
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | Michael K. Kim, Michael J. Daniels, William D. Rooney, Rebecca J. Willcocks, Glenn A. Walter, Krista H. Vandenborne |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2025
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
A new algorithm for sampling parameters in a structured correlation matrix with application to estimating optimal combinations of muscles to quantify progression in Duchenne muscular dystrophy
por: Kim, Michael K., et al.
Publicado: (2025)
por: Kim, Michael K., et al.
Publicado: (2025)
A model‐informed clinical trial simulation tool with a graphical user interface for Duchenne muscular dystrophy
por: Jongjin Kim, et al.
Publicado: (2024)
por: Jongjin Kim, et al.
Publicado: (2024)
Long‐Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History Comparisons
por: Craig M. McDonald, et al.
Publicado: (2025)
por: Craig M. McDonald, et al.
Publicado: (2025)
Immunoproteasome Inhibition Positively Impacts the Gut‐Muscle Axis in Duchenne Muscular Dystrophy
por: Andrea Farini, et al.
Publicado: (2025)
por: Andrea Farini, et al.
Publicado: (2025)
Discordant Monozygotic Triplets with Duchenne Muscular Dystrophy
por: Liang Wang, et al.
Publicado: (2024)
por: Liang Wang, et al.
Publicado: (2024)
Quantitative Muscle Ultrasound: A Non‐Invasive Biomarker for Monitoring Duchenne Muscular Dystrophy
por: Yu Jin Im, et al.
Publicado: (2025)
por: Yu Jin Im, et al.
Publicado: (2025)
Duchenne Muscular Dystrophy Idea Development Award (DOD)
Publicado: (2024)
Publicado: (2024)
Quantitative MRI Findings and Their Relationship to Muscle Histopathology and Ambulatory Clinical Function in Duchenne Muscular Dystrophy
por: Yanyu Lu, et al.
Publicado: (2026)
por: Yanyu Lu, et al.
Publicado: (2026)
Late‐Stage Skeletal Muscle Transcriptome in Duchenne Muscular Dystrophy Shows a BMP4‐Induced Molecular Signature
por: Hanna Sothers, et al.
Publicado: (2025)
por: Hanna Sothers, et al.
Publicado: (2025)
Prophylactic Use of Cardiac Medications and Survival in Duchenne Muscular Dystrophy
por: Kristin M. Conway, et al.
Publicado: (2025)
por: Kristin M. Conway, et al.
Publicado: (2025)
Incidence of Radiologically Confirmed Fractures in Adults With Duchenne Muscular Dystrophy
por: Gavin Langlands, et al.
Publicado: (2025)
por: Gavin Langlands, et al.
Publicado: (2025)
Multi‐Parametric Quantitative MRI in the Early Differential Diagnosis of Ambulatory Children With Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
por: Fei Peng, et al.
Publicado: (2025)
por: Fei Peng, et al.
Publicado: (2025)
Assessing Pharmacogenomic loci Associated with the Pharmacokinetics of Vamorolone in Boys with Duchenne Muscular Dystrophy
por: Xiaonan Li, et al.
Publicado: (2024)
por: Xiaonan Li, et al.
Publicado: (2024)
Proteomic Profiling of Myofiber Repair Annexins and Their Role in Duchenne Muscular Dystrophy
por: Paul Dowling, et al.
Publicado: (2025)
por: Paul Dowling, et al.
Publicado: (2025)
Serum Creatine Kinase and Transaminase Levels in Duchenne and Becker Muscular Dystrophies
por: Marie Rohlenová, et al.
Publicado: (2025)
por: Marie Rohlenová, et al.
Publicado: (2025)
Exploring Desmin as a Potential Modifier in Duchenne Muscular Dystrophy–Associated Cardiomyopathy
por: Brice‐Emmanuel Guennec, et al.
Publicado: (2025)
por: Brice‐Emmanuel Guennec, et al.
Publicado: (2025)
Survival in eteplirsen‐treated Duchenne Muscular Dystrophy patients: Are there benefits beyond steroids?
por: W. Bryan Burnette
Publicado: (2024)
por: W. Bryan Burnette
Publicado: (2024)
Longitudinal assessment of grip strength using bulb dynamometer in Duchenne Muscular Dystrophy
por: Tatiana M. Pizzato
Publicado: (2014)
por: Tatiana M. Pizzato
Publicado: (2014)
Direct AMPK Activation Confers Mutation‐Independent Therapeutic Benefit in Duchenne Muscular Dystrophy
por: Sean Y. Ng, et al.
Publicado: (2026)
por: Sean Y. Ng, et al.
Publicado: (2026)
Using Multiple Anthropomorphic Measures to Estimate Height in Muscular Dystrophies and Its Impact on Lung Function
por: Kayleen Whitley, et al.
Publicado: (2025)
por: Kayleen Whitley, et al.
Publicado: (2025)
Improvement of Spontaneous Locomotor Activity in a Murine Model of Duchenne Muscular Dystrophy by N‐Acetylglucosamine Alone and in Combination With Prednisolone
por: Masahiko. S. Satoh, et al.
Publicado: (2025)
por: Masahiko. S. Satoh, et al.
Publicado: (2025)
Harnessing Fast Fourier Transform for Rapid Community Travel Distance and Step Estimation in Children with Duchenne Muscular Dystrophy
por: Henricson, Erik K., et al.
Publicado: (2025)
por: Henricson, Erik K., et al.
Publicado: (2025)
Anaphylaxis During Delandistrogene Moxeparvovec Infusion Therapy in a Boy With Duchenne Muscular Dystrophy
por: Regina Laine, et al.
Publicado: (2025)
por: Regina Laine, et al.
Publicado: (2025)
D‐ and L‐Amino Acid Blood Concentrations Are Affected in Children With Duchenne Muscular Dystrophy
por: Martina Garofalo, et al.
Publicado: (2025)
por: Martina Garofalo, et al.
Publicado: (2025)
Metabolic Complications and Ultrasound‐Detected Liver Abnormalities in Paediatric Patients With Duchenne Muscular Dystrophy
por: Karolina Śledzińska, et al.
Publicado: (2026)
por: Karolina Śledzińska, et al.
Publicado: (2026)
Validity and Reliability of the 6‐min Pegboard and Ring Test in Patients With Duchenne Muscular Dystrophy
por: Çağtay Maden, et al.
Publicado: (2024)
por: Çağtay Maden, et al.
Publicado: (2024)
Specificities of the DMD Point Variant Spectrum in Russian Patients With Duchenne/Becker Muscular Dystrophy
por: Elena Zinina, et al.
Publicado: (2025)
por: Elena Zinina, et al.
Publicado: (2025)
Current Trends in Duchenne Muscular Dystrophy Research and Therapy: 3D Cardiac Modelling
por: Marta Przymuszała, et al.
Publicado: (2026)
por: Marta Przymuszała, et al.
Publicado: (2026)
Patient With Duchenne Muscular Dystrophy Who Tolerated Viltolarsen After Prior Anaphylaxis to Golodirsen
por: Julia Bassell‐Hawkins, et al.
Publicado: (2025)
por: Julia Bassell‐Hawkins, et al.
Publicado: (2025)
Longitudinal Outcomes Among Patients With Duchenne Muscular Dystrophy: A Canadian Retrospective Population‐Based Study
por: Christina Qian, et al.
Publicado: (2025)
por: Christina Qian, et al.
Publicado: (2025)
Longitudinal Follow‐Up of Patients With Duchenne Muscular Dystrophy Using Quantitative 23 Na and 1 H MRI
por: Teresa Gerhalter, et al.
Publicado: (2025)
por: Teresa Gerhalter, et al.
Publicado: (2025)
Joint Modelling of Growth and Motor Function Centiles in Corticosteroids Treated Boys With Duchenne Muscular Dystrophy
por: Georgia Stimpson, et al.
Publicado: (2025)
por: Georgia Stimpson, et al.
Publicado: (2025)
A Damage-Driven Model for Duchenne Muscular Dystrophy: Early-Stage Dynamics and Invasion Thresholds
por: Gambino, Gaetana, et al.
Publicado: (2026)
por: Gambino, Gaetana, et al.
Publicado: (2026)
Universal Proteomic Signature After Exercise‐Induced Muscle Injury in Muscular Dystrophies
por: Mads G. Stemmerik, et al.
Publicado: (2025)
por: Mads G. Stemmerik, et al.
Publicado: (2025)
Relationship Between Quantitative Magnetic Resonance Imaging Measures and Functional Changes in Patients With Duchenne Muscular Dystrophy
por: Sarah P. Sherlock, et al.
Publicado: (2024)
por: Sarah P. Sherlock, et al.
Publicado: (2024)
Effects of Bisphosphonates on Bone Micro‐Architecture of Children With Duchenne Muscular Dystrophy: A Prospective Comparative Study
por: Songqi Wang, et al.
Publicado: (2026)
por: Songqi Wang, et al.
Publicado: (2026)
Asynchrony Related to Mechanical Ventilation Exacerbates Diaphragm Dysfunction in a Mouse Model of Duchenne Muscular Dystrophy
por: Mohamad Yehya, et al.
Publicado: (2026)
por: Mohamad Yehya, et al.
Publicado: (2026)
Improving the Identification of Muscular Dystrophies From Their Mimickers Based on MRI Muscle Texture Features Combined With Clinical Biomarkers
por: Xinyue Niu, et al.
Publicado: (2026)
por: Xinyue Niu, et al.
Publicado: (2026)
Imaging Features of Skeletal Muscle and Their Correlation With Clinical Findings in Emery–Dreifuss Muscular Dystrophy Caused by EMD Variants
por: Rui Shimazaki, et al.
Publicado: (2026)
por: Rui Shimazaki, et al.
Publicado: (2026)
Neurotrophins, cytokines, oxidative parameters and functionality in Progressive Muscular Dystrophies
por: CLARISSA M. COMIM
Publicado: (2015)
por: CLARISSA M. COMIM
Publicado: (2015)
Ejemplares similares
-
A new algorithm for sampling parameters in a structured correlation matrix with application to estimating optimal combinations of muscles to quantify progression in Duchenne muscular dystrophy
por: Kim, Michael K., et al.
Publicado: (2025) -
A model‐informed clinical trial simulation tool with a graphical user interface for Duchenne muscular dystrophy
por: Jongjin Kim, et al.
Publicado: (2024) -
Long‐Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History Comparisons
por: Craig M. McDonald, et al.
Publicado: (2025) -
Immunoproteasome Inhibition Positively Impacts the Gut‐Muscle Axis in Duchenne Muscular Dystrophy
por: Andrea Farini, et al.
Publicado: (2025) -
Discordant Monozygotic Triplets with Duchenne Muscular Dystrophy
por: Liang Wang, et al.
Publicado: (2024)